Skip to main navigation Skip to search Skip to main content

Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

  • on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology
  • , Council on Cardiovascular Disease in the Young
  • , Council on Cardiovascular and Stroke Nursing
  • , Council on Functional Genomics and Translational Biology
  • , American College of Cardiology

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)e273-e280
JournalCirculation
Volume132
Issue number22
DOIs
StatePublished - Dec 1 2015

Keywords

  • AHA Scientific Statements
  • arrhythmogenic right ventricular cardiomyopathy
  • athletes
  • cardiomyopathy
  • cardiovascular abnormalities
  • cardiovascular magnetic resonance
  • hypertrophic cardiomyopathy
  • myocarditis
  • sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this